Add like
Add dislike
Add to saved papers

Clinicopathologic characteristics and survival of patients with gastroenteropancreatic neuroendocrine neoplasm (GEPNEN) in a multi-ethnic Asian institution <br><br><br><br><br><br>.

Neuroendocrinology 2018 November 7
<br>Background Epidemiological evidence suggests there are differences in gastroenteropancreatic neuroendocrine neoplasm (GEPNEN) among population groups. We aimed to contribute to the current evidence by evaluating the clinicopathologic characteristics of GEPNEN in a multi-ethnic Asian group. Materials and methods This was a retrospective chart review of patients diagnosed with GEPNEN at a tertiary medical institution at Singhealth Outram Campus, Singapore between 1995 and 2015. Results Two hundred ninety-five patients were included in the evaluation; comprising of Chinese (74.6%), Malay (4.4%), Indian (9.5%) and others (11.5%) ethnic backgrounds. Median age at diagnosis was 59, 52.5% were males. Distribution of disease stage at diagnosis was: localised (42.4%), regional (15.3%) and distant (38.0%). The three most common primary tumour sites were located in the pancreas (38.6%), rectum (19.7%) and stomach (9.5%), which varied significantly with ethnic background and age at diagnosis. Malay patients were younger (median 42 years) at diagnosis than Chinese (60 years). Patients with an appendiceal neuroendocrine neoplasm (NEN) (48 years) were younger compared to esophageal NEN (66 years). Disease stage correlated with primary tumour site and grade (p<0.001). Median overall survival (OS) for all GEPNEN was 10.2 years. Age at diagnosis, disease stage, and grading were prognostic factors of overall survival (OS) in multivariable analyses. Conclusion Our findings correspond with other studies that focus on GEPNEN incidences in Asian countries, with pancreas, rectum and stomach being the most common primary tumour sites. Our findings suggest racial differences in primary tumour site and age of diagnosis. Further prospective population-based registries are required to understand these epidemiological differences. <br>.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app